annual D&A:
$201.52M+$22.25M(+12.41%)Summary
- As of today (June 7, 2025), RDY annual depreciation & amortization is $201.52 million, with the most recent change of +$22.25 million (+12.41%) on March 1, 2025.
- During the last 3 years, RDY annual D&A has risen by +$42.80 million (+26.96%).
- RDY annual D&A is now at all-time high.
Performance
RDY Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$53.52M-$1.57M(-2.84%)Summary
- As of today (June 7, 2025), RDY quarterly depreciation & amortization is $53.52 million, with the most recent change of -$1.57 million (-2.84%) on March 1, 2025.
- Over the past year, RDY quarterly D&A has increased by +$7.89 million (+17.29%).
- RDY quarterly D&A is now -2.84% below its all-time high of $55.08 million, reached on December 31, 2024.
Performance
RDY quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$201.52M+$7.89M(+4.07%)Summary
- As of today (June 7, 2025), RDY TTM depreciation & amortization is $201.52 million, with the most recent change of +$7.89 million (+4.07%) on March 1, 2025.
- Over the past year, RDY TTM D&A has increased by +$22.25 million (+12.41%).
- RDY TTM D&A is now at all-time high.
Performance
RDY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RDY Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +12.4% | +17.3% | +12.4% |
3 y3 years | +27.0% | +32.3% | +27.0% |
5 y5 years | +14.8% | +26.5% | +14.8% |
RDY Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +27.9% | -2.8% | +42.2% | at high | +29.6% |
5 y | 5-year | at high | +27.9% | -2.8% | +42.2% | at high | +29.6% |
alltime | all time | at high | +932.3% | -2.8% | +1084.1% | at high | +4033.8% |
RDY Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | $201.52M(+12.4%) | $53.52M(-2.8%) | $201.52M(+4.1%) |
Dec 2024 | - | $55.08M(+16.6%) | $193.64M(+5.7%) |
Sep 2024 | - | $47.26M(+3.5%) | $183.21M(+0.9%) |
Jun 2024 | - | $45.67M(+0.1%) | $181.50M(+1.2%) |
Mar 2024 | $179.27M(+13.7%) | $45.63M(+2.2%) | $179.27M(+1.7%) |
Dec 2023 | - | $44.66M(-1.9%) | $176.21M(+4.2%) |
Sep 2023 | - | $45.55M(+4.8%) | $169.18M(+4.7%) |
Jun 2023 | - | $43.44M(+2.1%) | $161.51M(+2.5%) |
Mar 2023 | $157.60M(-0.7%) | $42.56M(+13.1%) | $157.60M(+1.4%) |
Dec 2022 | - | $37.63M(-0.7%) | $155.49M(-0.7%) |
Sep 2022 | - | $37.88M(-4.2%) | $156.65M(-1.4%) |
Jun 2022 | - | $39.53M(-2.3%) | $158.87M(+0.1%) |
Mar 2022 | $158.73M(-7.7%) | $40.45M(+4.3%) | $158.73M(-0.9%) |
Dec 2021 | - | $38.78M(-3.3%) | $160.16M(-3.2%) |
Sep 2021 | - | $40.10M(+1.8%) | $165.53M(-2.8%) |
Jun 2021 | - | $39.39M(-6.0%) | $170.23M(-1.1%) |
Mar 2021 | $172.05M(-2.0%) | $41.89M(-5.1%) | $172.05M(-0.2%) |
Dec 2020 | - | $44.16M(-1.4%) | $172.46M(+1.1%) |
Sep 2020 | - | $44.79M(+8.7%) | $170.58M(-1.2%) |
Jun 2020 | - | $41.22M(-2.5%) | $172.59M(-1.7%) |
Mar 2020 | $175.63M(+0.8%) | $42.29M(+0.0%) | $175.63M(-3.3%) |
Dec 2019 | - | $42.28M(-9.7%) | $181.62M(+0.9%) |
Sep 2019 | - | $46.81M(+5.8%) | $180.06M(+3.5%) |
Jun 2019 | - | $44.25M(-8.4%) | $174.01M(-0.1%) |
Mar 2019 | $174.26M(-4.1%) | $48.28M(+18.6%) | $174.26M(+0.8%) |
Dec 2018 | - | $40.73M(-0.1%) | $172.95M(-2.6%) |
Sep 2018 | - | $40.75M(-8.4%) | $177.60M(-2.8%) |
Jun 2018 | - | $44.50M(-5.3%) | $182.74M(+0.6%) |
Mar 2018 | $181.63M(+8.0%) | $46.97M(+3.5%) | $181.63M(+2.1%) |
Dec 2017 | - | $45.37M(-1.1%) | $177.92M(+1.7%) |
Sep 2017 | - | $45.89M(+5.7%) | $174.87M(+2.0%) |
Jun 2017 | - | $43.40M(+0.3%) | $171.50M(+2.0%) |
Mar 2017 | $168.17M(+7.3%) | $43.27M(+2.2%) | $168.17M(-1.5%) |
Dec 2016 | - | $42.32M(-0.5%) | $170.71M(+2.6%) |
Sep 2016 | - | $42.51M(+6.1%) | $166.37M(+3.3%) |
Jun 2016 | - | $40.07M(-12.5%) | $161.01M(+2.8%) |
Mar 2016 | $156.69M(+18.2%) | $45.80M(+20.6%) | $156.69M(+5.4%) |
Dec 2015 | - | $37.98M(+2.2%) | $148.63M(+4.5%) |
Sep 2015 | - | $37.15M(+3.9%) | $142.24M(+3.9%) |
Jun 2015 | - | $35.75M(-5.3%) | $136.97M(+3.4%) |
Mar 2015 | $132.51M(+12.4%) | $37.74M(+19.5%) | $132.51M(+2.1%) |
Dec 2014 | - | $31.59M(-0.9%) | $129.82M(+2.0%) |
Sep 2014 | - | $31.88M(+1.9%) | $127.23M(+5.8%) |
Jun 2014 | - | $31.30M(-10.7%) | $120.26M(+2.0%) |
Mar 2014 | $117.93M(+15.5%) | $35.05M(+20.9%) | $117.93M(+7.1%) |
Dec 2013 | - | $29.00M(+16.4%) | $110.11M(+2.4%) |
Sep 2013 | - | $24.91M(-14.0%) | $107.55M(+0.5%) |
Jun 2013 | - | $28.97M(+6.4%) | $107.01M(+4.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2013 | $102.10M(-6.5%) | $27.24M(+3.0%) | $102.10M(-6.4%) |
Dec 2012 | - | $26.43M(+8.5%) | $109.05M(+6.0%) |
Sep 2012 | - | $24.37M(+1.3%) | $102.92M(-2.6%) |
Jun 2012 | - | $24.06M(-29.6%) | $105.71M(-3.2%) |
Mar 2012 | $109.25M(+19.9%) | $34.19M(+68.5%) | $109.25M(+12.4%) |
Dec 2011 | - | $20.30M(-25.3%) | $97.17M(-5.0%) |
Sep 2011 | - | $27.16M(-1.6%) | $102.27M(+5.1%) |
Jun 2011 | - | $27.60M(+24.8%) | $97.31M(+6.8%) |
Mar 2011 | $91.11M(+3.7%) | $22.11M(-12.9%) | $91.11M(+2.4%) |
Dec 2010 | - | $25.40M(+14.4%) | $88.99M(+1.6%) |
Sep 2010 | - | $22.20M(+3.7%) | $87.56M(+1.9%) |
Jun 2010 | - | $21.40M(+7.1%) | $85.94M(-2.1%) |
Mar 2010 | $87.83M(+5.7%) | $19.99M(-16.6%) | $87.83M(-5.0%) |
Dec 2009 | - | $23.98M(+16.5%) | $92.46M(+11.1%) |
Sep 2009 | - | $20.58M(-11.6%) | $83.24M(-0.9%) |
Jun 2009 | - | $23.29M(-5.4%) | $84.00M(+1.1%) |
Mar 2009 | $83.10M(-0.9%) | $24.62M(+67.0%) | $83.10M(+1.3%) |
Dec 2008 | - | $14.75M(-30.9%) | $82.01M(-7.8%) |
Sep 2008 | - | $21.34M(-4.7%) | $88.95M(+0.8%) |
Jun 2008 | - | $22.40M(-4.8%) | $88.24M(+5.2%) |
Mar 2008 | $83.89M(+25.3%) | $23.53M(+8.5%) | $83.89M(+6.8%) |
Dec 2007 | - | $21.68M(+5.1%) | $78.53M(+6.8%) |
Sep 2007 | - | $20.63M(+14.3%) | $73.51M(+6.7%) |
Jun 2007 | - | $18.05M(-0.6%) | $68.88M(+2.9%) |
Mar 2007 | $66.97M(+88.1%) | $18.17M(+9.1%) | $66.97M(+11.2%) |
Dec 2006 | - | $16.66M(+4.1%) | $60.20M(+17.9%) |
Sep 2006 | - | $16.00M(-0.8%) | $51.07M(+18.1%) |
Jun 2006 | - | $16.14M(+41.6%) | $43.25M(+21.5%) |
Mar 2006 | $35.61M(+21.8%) | $11.40M(+51.3%) | $35.61M(+5.8%) |
Dec 2005 | - | $7.53M(-7.9%) | $33.65M(+3.8%) |
Sep 2005 | - | $8.18M(-3.7%) | $32.43M(+4.2%) |
Jun 2005 | - | $8.50M(-10.0%) | $31.13M(+6.5%) |
Mar 2005 | $29.24M(+18.7%) | $9.44M(+49.6%) | $29.24M(+11.5%) |
Dec 2004 | - | $6.31M(-8.3%) | $26.22M(-0.3%) |
Sep 2004 | - | $6.88M(+4.2%) | $26.30M(+3.1%) |
Jun 2004 | - | $6.61M(+2.8%) | $25.52M(+3.6%) |
Mar 2004 | $24.62M(+17.5%) | $6.42M(+0.6%) | $24.62M(+5.0%) |
Dec 2003 | - | $6.38M(+4.6%) | $23.45M(+4.4%) |
Sep 2003 | - | $6.10M(+6.8%) | $22.47M(+5.4%) |
Jun 2003 | - | $5.71M(+8.7%) | $21.32M(+1.7%) |
Mar 2003 | $20.96M(+5.9%) | $5.25M(-2.7%) | $20.96M(-1.5%) |
Dec 2002 | - | $5.40M(+9.0%) | $21.28M(+4.3%) |
Sep 2002 | - | $4.95M(-7.4%) | $20.40M(+0.7%) |
Jun 2002 | - | $5.35M(-4.2%) | $20.26M(+2.4%) |
Mar 2002 | $19.79M(+1.4%) | $5.58M(+23.5%) | $19.79M(+39.3%) |
Dec 2001 | - | $4.52M(-6.1%) | $14.21M(+46.6%) |
Sep 2001 | - | $4.81M(-1.3%) | $9.69M(+98.7%) |
Jun 2001 | - | $4.88M | $4.88M |
Mar 2001 | $19.52M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual depreciation & amortization?
- What is the all time high annual D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual D&A year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly D&A year-on-year change?
- What is Dr Reddys Laboratories Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM D&A year-on-year change?
What is Dr Reddys Laboratories Limited annual depreciation & amortization?
The current annual D&A of RDY is $201.52M
What is the all time high annual D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual depreciation & amortization is $201.52M
What is Dr Reddys Laboratories Limited annual D&A year-on-year change?
Over the past year, RDY annual depreciation & amortization has changed by +$22.25M (+12.41%)
What is Dr Reddys Laboratories Limited quarterly depreciation & amortization?
The current quarterly D&A of RDY is $53.52M
What is the all time high quarterly D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly depreciation & amortization is $55.08M
What is Dr Reddys Laboratories Limited quarterly D&A year-on-year change?
Over the past year, RDY quarterly depreciation & amortization has changed by +$7.89M (+17.29%)
What is Dr Reddys Laboratories Limited TTM depreciation & amortization?
The current TTM D&A of RDY is $201.52M
What is the all time high TTM D&A for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM depreciation & amortization is $201.52M
What is Dr Reddys Laboratories Limited TTM D&A year-on-year change?
Over the past year, RDY TTM depreciation & amortization has changed by +$22.25M (+12.41%)